ArticleScientific reports2026

Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study.

Jae Ryong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.